| William George Grammond, | |
|
3500 Tower Ave, Superior, WI 54880-5335 | |
| (715) 817-7880 | |
| (715) 395-3178 |
| Full Name | William George Grammond |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3500 Tower Ave, Superior, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477893493 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 7837 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William George Grammond, 3500 Tower Ave, Superior, WI 54880-5335 Ph: (715) 817-7880 | William George Grammond, 3500 Tower Ave, Superior, WI 54880-5335 Ph: (715) 817-7880 |
News Archive
Cerus Corporation announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. The INTERCEPT red blood cell system is a pathogen inactivation treatment the company is developing to protect against transmission of infectious diseases through red blood cell transfusions. An estimated 70 million units of red blood cells are transfused worldwide each year.
The 7.5 millilitres of blood contained in a standard sample tube is not nearly enough to detect circulating tumour cells (CTCs) in the blood of patients with metastatic breast cancer, prostate cancer, or colorectal cancer with a high enough degree of reliability. These CTCs are the cause of metastases in cancer patients. If they can be effectively characterized, it is possible to arrive at a prognosis and to determine the most effective course of treatment.
Atherotech Inc. announced it will exhibit its VAP® Cholesterol Test in booth #1305 at Internal Medicine 2010, the annual scientific meeting of the American College of Physicians (ACP). The meeting takes place April 22-24, 2010, at the Metro Toronto Convention Centre in Toronto, Canada.
A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test. This is one more piece of information to aid in the identification and early treatment of individuals most likely to develop Alzheimer's disease.
› Verified 9 days ago
Dr. Jason Kerska, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2015 Tower Ave, Superior, WI 54880 Phone: 715-392-9550 | |
Mr. James Francis Sheahan Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3535 Tower Ave, Superior, WI 54880 Phone: 715-392-9876 Fax: 715-392-9876 | |
Nicholas Fetter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3015 Tower Ave, Superior, WI 54880 Phone: 715-394-5551 | |
Katherine Adele Haas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3500 Tower Ave, Superior, WI 54880 Phone: 715-817-7100 | |
Kathy Gore, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3705 Tower Ave, Superior, WI 54880 Phone: 715-392-9520 | |
Rodneyt Tester, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2015 Tower Ave, Superior, WI 54880 Phone: 715-392-9550 Fax: 715-392-3724 | |
Nicholas Rickoff, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 Belknap St Ste 100, Superior, WI 54880 Phone: 715-817-7224 Fax: 715-817-7193 |